New Progress in the Hair Loss Prevention Drug Market: JAK Inhibitor Baricitinib Reaches Phase 3 Clinical Primary Endpoint

PharmaSources.comMarch 26, 2021

Tag: Baricitinib , Incyte , Eli Lilly , Olumiant , hair loss